当前位置: 首页 >> 检索结果
161. A systematic review of the patient burden of Crohn's disease-related rectovaginal and anovaginal fistulas.
作者: Kristy Iglay.;Dimitri Bennett.;Michael D Kappelman.;Sydney Thai.;Molly Aldridge.;Chitra Karki.;Suzanne F Cook.
来源: BMC Gastroenterol. 2022年22卷1期36页
Crohn's disease (CD)-related rectovaginal fistulas (RVFs) and anovaginal fistulas (AVFs) are rare, debilitating conditions that present a substantial disease and treatment burden for women. This systematic literature review (SLR) assessed the burden of Crohn's-related RVF and AVF, summarizing evidence from observational studies and highlighting knowledge gaps.
162. Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review.
作者: M Ellen Kuenzig.;Stephen G Fung.;Luba Marderfeld.;Joyce W Y Mak.;Gilaad G Kaplan.;Siew C Ng.;David C Wilson.;Fiona Cameron.;Paul Henderson.;Paulo G Kotze.;Jasmine Bhatti.;Vixey Fang.;Samantha Gerber.;Evelyne Guay.;Supun Kotteduwa Jayawarden.;Leo Kadota.;Fernando Maldonado D.;Jessica Amankwah Osei.;Ryan Sandarage.;Amanda Stanton.;Melissa Wan.; .;Eric I Benchimol.
来源: Gastroenterology. 2022年162卷4期1147-1159.e4页
The incidence of inflammatory bowel disease (IBD) is increasing internationally, particularly in nations with historically low rates. Previous reports of the epidemiology of pediatric-onset IBD identified a paucity of data. We systematically reviewed the global trends in incidence and prevalence of IBD diagnosed in individuals <21 years old over the first 2 decades of the 21st century.
163. Clinical and Endoscopic Characteristics Associated With Post-Endoscopy Upper Gastrointestinal Cancers: A Systematic Review and Meta-analysis.
作者: Leo Alexandre.;Theo Tsilegeridis-Legeris.;Stephen Lam.
来源: Gastroenterology. 2022年162卷4期1123-1135页
Ten percent of patients with an upper gastrointestinal cancer will have received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed post-endoscopy upper gastrointestinal cancers (PEUGIC). We aimed to determine the characteristics of PEUGIC, and compare these with detected cancers.
164. Is it time to rethink the burden of non-coeliac gluten sensitivity? A systematic review.
作者: Federica Borrelli DE Andreis.;Annalisa Schiepatti.;Giulia Gibiino.;Carlo Fabbri.;Paola Baiardi.;Federico Biagi.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期442-449页
Non-coeliac gluten sensitivity (NCGS) is still a poorly defined clinical condition. This review aims to describe the clinical features of subjects with a symptomatic response to gluten intake, and to estimate the prevalence of NCGS.
165. The physiological and psychological effects of cognitive behavior therapy on patients with inflammatory bowel disease before COVID-19: a systematic review.
作者: Jie Chen.;Xuejie Chen.;Yuhao Sun.;Ying Xie.;Xiaoyan Wang.;Ran Li.;Therese Hesketh.
来源: BMC Gastroenterol. 2021年21卷1期469页
Cognitive behavioral therapy (CBT) is now included in the treatment of patients with inflammatory bowel disease (IBD) in many settings. However, different clinical trials report different outcomes without consensus. This study aims to evaluate the impact of CBT on the mental state, quality of life and disease activity of patients with IBD.
166. Helicobacter pylori infection is associated with reduced risk of Barrett's esophagus: a meta-analysis and systematic review.
Helicobacter pylori (Hp) is a class I carcinogen in gastric carcinogenesis, but its role in Barrett's esophagus (BE) is unknown. Therefore, we aimed to explore the possible relationship.
167. Late-Stage Pancreatic Cancer Detected During High-Risk Individual Surveillance: A Systematic Review and Meta-Analysis.
作者: Ankit Chhoda.;Ziga Vodusek.;Kapil Wattamwar.;Eric Mukherjee.;Craig Gunderson.;Alyssa Grimshaw.;Anup Sharma.;Nita Ahuja.;Fay Kastrinos.;James J Farrell.
来源: Gastroenterology. 2022年162卷3期786-798页
Identification and resection of successful targets, that is, T1 N0M0 pancreatic ductal adenocarcinoma (PDAC) and high-grade precursors during surveillance of high-risk individuals (HRIs) confers improved survival. Late-stage PDACs refer to T2-4 N0M0 and nodal or distant metastatic PDAC stages diagnosed during the follow-up phase of HRI surveillance. This study aimed to quantify late-stage PDACs during HRI surveillance and identify associated clinicoradiologic factors.
168. Clinicopathological significance of HSP70 expression in gastric cancer: a systematic review and meta-analysis.
Heat shock protein 70 (HSP70) has been associated with the clinicopathological characteristics and prognosis of many cancers types, implying that it is a potential cancer biomarker. However, no consensus has been reached regarding its clinicopathological and prognostic significance in patients with gastric cancer. To address this gap, we performed a systematic review and meta-analysis.
169. Efficacy of Biologic Drugs in Short-Duration Versus Long-Duration Inflammatory Bowel Disease: A Systematic Review and an Individual-Patient Data Meta-Analysis of Randomized Controlled Trials.
作者: Shomron Ben-Horin.;Lena Novack.;Ren Mao.;Jing Guo.;Yue Zhao.;Ruslan Sergienko.;Jian Zhang.;Taku Kobayashi.;Toshifumi Hibi.;Yehuda Chowers.;Laurent Peyrin-Biroulet.;Jean Frederic Colombel.;Gilaad G Kaplan.;Min-Hu Chen.
来源: Gastroenterology. 2022年162卷2期482-494页
Starting biologic treatment early in the course of inflammatory bowel disease (IBD) may be associated with higher efficacy, especially in Crohn's disease (CD).
170. Serologic Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Patients With Immune-Mediated Inflammatory Diseases: A Systematic Review and Meta-analysis.
Patients with immune-mediated inflammatory diseases (IMIDs) have an increased risk of coronavirus disease 2019 (COVID-19), primarily attributed to the use of immunosuppressive drugs such as glucocorticoids, which may attenuate the response to vaccines. This meta-analysis assessed the serologic response to COVID-19 vaccination in patients with IMIDs.
171. Underrepresentation of Minorities and Underreporting of Race and Ethnicity in Crohn's Disease Clinical Trials.
作者: Rocio Sedano.;Malcolm Hogan.;Cassandra Mcdonald.;Tina Aswani-Omprakash.;Christopher Ma.;Vipul Jairath.
来源: Gastroenterology. 2022年162卷1期338-340.e2页 173. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis.
作者: Robert S O'Shea.;Perica Davitkov.;Cynthia W Ko.;Anita Rajasekhar.;Grace L Su.;Shahnaz Sultan.;Alina M Allen.;Yngve Falck-Ytter.
来源: Gastroenterology. 2021年161卷5期1615-1627.e1页 174. Global Incidence of Acute Pancreatitis Is Increasing Over Time: A Systematic Review and Meta-Analysis.
作者: Jordan P Iannuzzi.;James A King.;Jessica Hope Leong.;Joshua Quan.;Joseph W Windsor.;Divine Tanyingoh.;Stephanie Coward.;Nauzer Forbes.;Steven J Heitman.;Abdel-Aziz Shaheen.;Mark Swain.;Michael Buie.;Fox E Underwood.;Gilaad G Kaplan.
来源: Gastroenterology. 2022年162卷1期122-134页
Acute pancreatitis is a common disease with significant associated morbidity and mortality. We performed a systematic review and meta-analysis of population-based studies to explore the changing temporal trends of acute pancreatitis incidence globally.
176. The association between irritable bowel syndrome and ischemic colitis: a systematic review and meta-analysis.
作者: Wasit Wongtrakul.;Nipith Charoenngam.;Patompong Ungprasert.
来源: Minerva Gastroenterol (Torino). 2022年68卷4期470-474页
Studies have suggested an association between ischemic colitis and irritable bowel syndrome (IBS) although the results were inconsistent. This systematic review and meta-analysis were performed to comprehensively examine the association between IBS and ischemic colitis by identifying all available cohort and case-control studies and combining their effect estimates together.
177. Efficiency of complete omentectomy in patients with resectable gastric cancer: a meta‑analysis and systematic review.
作者: Akao Zhu.;Guang Yin.;Xinchun Liu.;Wencheng Kong.;Yu Zhang.;Yuqiang Shan.;Rongchao Ying.;Jian Zhang.;Chunhua Zhou.
来源: BMC Gastroenterol. 2021年21卷1期346页
We performed a meta-analysis to investigate the efficacy of complete omentectomy (CO) in patients undergoing radical gastrectomy for gastric cancer.
178. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
作者: Brigida Barberio.;Davide Massimi.;Nora Cazzagon.;Fabiana Zingone.;Alexander C Ford.;Edoardo V Savarino.
来源: Gastroenterology. 2021年161卷6期1865-1877页
Although the association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) is well recognized, uncertainties remain about the magnitude of this problem. We conducted a systematic review and meta-analysis assessing prevalence of PSC in IBD to investigate whether type of IBD, how presence of PSC was defined, sex, disease extent or location, time period, or geographic location influenced prevalence.
179. Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis.
作者: Shailja C Shah.;Adam Tepler.;Cecilia P Chung.;Giovanni Suarez.;Richard M Peek.;Adriana Hung.;Christianne Roumie.;Neeraj Narula.
来源: Gastroenterology. 2021年161卷5期1443-1459页
Helicobacter pylori infects approximately 50% of individuals worldwide. Successful H pylori eradication is associated with reduced risk of gastric cancer and peptic ulcer disease, among other conditions. We hypothesized that host genetic determinants, especially those affecting gastric pH, might contribute to eradication therapy failure, particularly when treatment adherence and antibiotic susceptibility are confirmed. We aimed to conduct a meta-analysis of host genetic variants associated with H pylori eradication failure.
180. Systematic review and meta-analysis: real-world data rates of deep remission with anti-TNFα in inflammatory bowel disease.
Deep remission (DR) is a treatment target in IBD associated with reduced hospitalization and improved outcome. Randomized control trial (RCT) data demonstrates efficacy of anti-TNFα agents in achieving DR; however, real-world data (RWD) can provide information complementary to RCTs, specifically regarding treatment duration. In this systematic review with meta-analysis, we use real-world data (RWD) to determine rates of DR in IBD treated with anti-TNFα.
|